Isarna Therapeutics GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Date: November 17, 2014
Pages: 18
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: I5528BE6DCAEN
Leaflet:

Download PDF Leaflet

Isarna Therapeutics GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary

Isarna Therapeutics GmbH (Isarna) is a biotechnology company. The company conducts research and develops innovative pharmaceutical products. The company focuses on the development of antisense technology-based drugs for the treatment of aggressive tumor diseases. Antisense Pharma is an international leader in the development of TGF-? antisense drugs. Its lead product candidate, Trabedersen, targets the protein transforming growth factor beta 2 (TGF-?2). It is in Phase III clinical studies for the treatment of high-grade glioma and in Phase II studies for the treatment of malignant melanoma and advanced pancreatic cancer. The drug candidate was granted orphan drug designation in the US and EU for the treatment of high-grade glioma and pancreatic cancer, and only in the US for malignant melanoma. Other products under development include next generation antisense oligonucleotide candidates, which target different TGF-? isoforms for the treatment of solid tumors. Its investors include MIG Fonds, S-Refit AG, Global Asset Fund, Global Chance Fund, Technologie Beteiligungsgesellschaft mbH tbg, Technologie Beteiligungsfonds Bayern GmbH & Co. KG and GA Beteiligungs GmbH. Isarna Therapeutics is headquartered in Regensburg, Germany.

In line with its strategic intent of developing antisense technology-based drugs, Isarna Therapeutics entered into a strategic manufacturing agreement with Sanofi. Under this agreement Sanofi undertakes the manufacture of clinical- and commercial-grade antisense oligonucleotide (ASO) compounds for Isarna, facilitating Isarna to advance its promising next generation ASOs rapidly into clinical trials.

Isarna Therapeutics GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
  • The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
  • The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
  • Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
  • Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
  • Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company.
Isarna Therapeutics GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Isarna Therapeutics GmbH, Pharmaceuticals & Healthcare Deals By Type, 2008 to YTD 2014
Isarna Therapeutics GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014
Isarna Therapeutics GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014
Isarna Therapeutics GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2008 to YTD 2014
Isarna Therapeutics GmbH, Pharmaceuticals & Healthcare, Deal Details
Venture Financing
Isarna Therapeutics Raises US$7.6 Million In Venture Financing
Isarna Therapeutics Raises US$18 Million In Venture Financing
Antisense Pharma Raises US$11.6 Million In Venture Financing
Antisense Pharma Raises US$18 Million In Series E Financing
Licensing Agreements
Isarna Therapeutics Enters Into Licensing Agreement With Santaris Pharma To Develop Oligonucleotides For TGF-?-Mediated Diseases
Isarna Therapeutics GmbH - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Isarna Therapeutics GmbH, Pharmaceuticals & Healthcare, Key Facts
Isarna Therapeutics GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Isarna Therapeutics GmbH, Pharmaceuticals & Healthcare Deals By Type, 2008 to YTD 2014
Isarna Therapeutics GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014
Isarna Therapeutics GmbH, Deals By Therapy Area, 2008 to YTD 2014
Isarna Therapeutics GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2008 to YTD 2014
Isarna Therapeutics Raises US$7.6 Million In Venture Financing
Isarna Therapeutics Raises US$18 Million In Venture Financing
Antisense Pharma Raises US$11.6 Million In Venture Financing
Antisense Pharma Raises US$18 Million In Series E Financing
Isarna Therapeutics Enters Into Licensing Agreement With Santaris Pharma To Develop Oligonucleotides For TGF-?-Mediated Diseases
Isarna Therapeutics GmbH, Key Competitors
Isarna Therapeutics GmbH, Key Employees
Isarna Therapeutics GmbH, Other Locations

LIST OF FIGURES

Isarna Therapeutics GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014
Isarna Therapeutics GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Isarna Therapeutics GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014
Isarna Therapeutics GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014
Isarna Therapeutics GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Isarna Therapeutics GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014
Isarna Therapeutics GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014
Isarna Therapeutics GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014
Skip to top


Ask Your Question

Isarna Therapeutics GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: